150 related articles for article (PubMed ID: 3328519)
41. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
Reubsaet FA; Veerkamp JH; Brückwilder ML; Trijbels JM; Hashimoto T; Monnens LA
Biochim Biophys Acta; 1991 Jun; 1083(3):305-9. PubMed ID: 2049396
[TBL] [Abstract][Full Text] [Related]
42. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
43. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
Suzuki Y
No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
[TBL] [Abstract][Full Text] [Related]
44. Adrenoleukodystrophy, cerebrohepatorenal syndrome (Zellweger syndrome), and peroxisomes.
Applegarth DA; Dimmick JE
Pediatr Pathol; 1985; 3(2-4):377-8. PubMed ID: 4095031
[No Abstract] [Full Text] [Related]
45. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
46. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
[TBL] [Abstract][Full Text] [Related]
47. Improved determination of very-long-chain fatty acids in plasma and cultured skin fibroblasts: applications to the diagnosis of peroxisomal disorders.
Onkenhout W; van der Poel PF; van den Heuvel MP
J Chromatogr; 1989 Sep; 494():31-41. PubMed ID: 2479651
[TBL] [Abstract][Full Text] [Related]
48. Peroxisomal disorders. A review of a recently recognized group of clinical entities.
Talwar D; Swaiman KF
Clin Pediatr (Phila); 1987 Oct; 26(10):497-504. PubMed ID: 2443295
[TBL] [Abstract][Full Text] [Related]
49. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.
Moser AE; Singh I; Brown FR; Solish GI; Kelley RI; Benke PJ; Moser HW
N Engl J Med; 1984 May; 310(18):1141-6. PubMed ID: 6709009
[TBL] [Abstract][Full Text] [Related]
50. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
[TBL] [Abstract][Full Text] [Related]
51. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
Taketomi T; Hara A; Kitazawa N; Takada K; Nakamura H
Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
[TBL] [Abstract][Full Text] [Related]
52. [Peroxisomes and peroxisomal diseases].
Petelenz M; Gonciarz Z; Grzybek H; Panz B
Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
[TBL] [Abstract][Full Text] [Related]
53. Peroxisomal disorders in neurology.
Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
[TBL] [Abstract][Full Text] [Related]
54. Peroxisomal disorders.
Moser HW; Bergin A; Cornblath D
Biochem Cell Biol; 1991 Jul; 69(7):463-74. PubMed ID: 1724376
[TBL] [Abstract][Full Text] [Related]
55. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes.
Kelley RI; Datta NS; Dobyns WB; Hajra AK; Moser AB; Noetzel MJ; Zackai EH; Moser HW
Am J Med Genet; 1986 Apr; 23(4):869-901. PubMed ID: 3515938
[TBL] [Abstract][Full Text] [Related]
56. A new peroxisomal disorder with fetal and neonatal adrenal insufficiency.
Vanhole C; de Zegher F; Casaer P; Devlieger H; Wanders RJ; Vanhove G; Jaeken J
Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F55-6. PubMed ID: 8092875
[TBL] [Abstract][Full Text] [Related]
57. Peroxisomal fatty acid beta-oxidation in relation to adrenoleukodystrophy.
Wanders RJ; Tager JM
Dev Neurosci; 1991; 13(4-5):262-6. PubMed ID: 1817031
[TBL] [Abstract][Full Text] [Related]
58. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
[TBL] [Abstract][Full Text] [Related]
59. Adrenoleukodystrophy: abnormality of "tightly bound" fatty acids in the erythrocyte membrane proteins.
Antoku Y; Sakai T; Goto I; Miyoshino S; Iwashita H; Kuroiwa Y
Neurology; 1985 Oct; 35(10):1512-4. PubMed ID: 4033936
[TBL] [Abstract][Full Text] [Related]
60. Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy: a possible new peroxisomal disease entity.
Naidu S; Hoefler G; Watkins PA; Chen WW; Moser AB; Hoefler S; Rance NE; Powers JM; Beard M; Green WR
Neurology; 1988 Jul; 38(7):1100-7. PubMed ID: 3386829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
